$5.52
-0.15-2.65%
Last update: Oct 2, 7:33 PM
$5.56
-0.11-1.94%
Teladoc Health Inc
TDOCNYSE
Teladoc Health (TDOC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Teladoc Health (TDOC) last issued guidance on July 29, 2026 for Q3 2026. The company guided earnings per share in the range of $-0.3 - $-0.2, compared to a consensus EPS estimate of $-0.17. Teladoc Health also guided revenue in the range of $569M - $609M for the period.
Compared to prior guidance, Teladoc Health lowered its revenue forecast from a prior range of $2.36B - $2.45B.
Teladoc Health has issued 34 guidance updates between October 26, 2022 and July 29, 2026. During this period, the company raised its outlook 7 times and lowered it 15 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.24 | $-0.37 | $-0.21 | $-0.24 |
| Actual | $-0.21 | $-0.36 | $-0.14 | $-0.20 |
| Surprise | +12.5% | +2.70% | +33.3% | +16.7% |
| Revenue | ||||
| Estimate | $615.6M | $610.9M | $634.8M | $630.9M |
| Actual | $606.9M | $613.8M | $642.3M | $626.4M |
| Surprise | -1.41% | +0.48% | +1.18% | -0.71% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.21 | $-0.11 | $-0.24 | $-0.20 |
| Revenue | ||||
| Consensus | $591.0M | $602.9M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $-0.21 | $-0.24 | 12.5 % |
| Q1 | Apr 29, 2026 | $-0.36 | $-0.37 | 2.70 % |
| Q4 | Feb 25, 2026 | $-0.14 | $-0.21 | 33.3 % |
| Q3 | Oct 29, 2025 | $-0.20 | $-0.24 | 16.7 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $606.93M | $615.58M | -1.41 % |
| Q1 | Apr 29, 2026 | $613.85M | $610.93M | 0.48 % |
| Q4 | Feb 25, 2026 | $642.27M | $634.76M | 1.18 % |
| Q3 | Oct 29, 2025 | $626.44M | $630.93M | -0.71 % |
